Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Denardo

Showing results (141-150 of 274) with videos related to

Pageof 28
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1995
Pharmacokinetics of chimeric L6 conjugated to indium-111- and yttrium-90-DOTA-peptide in tumor-bearing miceS J DeNardo, G R Zhong, Q Salako, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 7, 2007
Selecting an intervention time for intravascular enzymatic cleavage of peptide linkers to clear radioisotope from normal tissuesChristine L Hartmann Siantar, Gerald L DeNardo, Kit Lam, et al.
Nuclear Medicine and Biology|January 1, 1997
Reproducibility of operator processing for radiation dosimetryS Shen, G L DeNardo, S J DeNardo, et al.
Bioorganic & Medicinal Chemistry Letters|August 15, 2008
Development of TNKase-specific cleavable peptide-linked radioimmunoconjugates for radioimmunotherapyArutselvan Natarajan, Pappanaicken R Kumaresan, Sally J Denardo, et al.
Cancer|December 24, 1997
Impact of splenomegaly on therapeutic response and I-131-LYM-1 dosimetry in patients with B-lymphocytic malignanciesS Shen, G L DeNardo, R T O'Donnell, et al.
Chemical Communications (Cambridge, England)|March 30, 2007
Construction of di-scFv through a trivalent alkyne-azide 1,3-dipolar cycloadditionArutselvan Natarajan, Wenjun Du, Cheng-Yi Xiong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1990
Metabolism of indium chelates attached to monoclonal antibody: minimal transchelation of indium from benzyl-EDTA chelate in vivoS V Deshpande, R Subramanian, M J McCall, et al.
Nuclear Medicine and Biology|May 1, 1996
A radioimmunoimaging and MIRD dosimetry treatment planning program for radioimmunotherapyW D Erwin, M W Groch, D J Macey, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 21, 1998
A preliminary cell kinetics model of thrombocytopenia after radioimmunotherapyS Shen, G L DeNardo, T D Jones, et al.
European Journal of Nuclear Medicine|August 1, 1996
Application of the linear-quadratic model to myelotoxicity associated with radioimmunotherapyR B Wilder, G L DeNardo, S Sheri, et al.
Pageof 28

Showing results (141-150 of 274) with videos related to

Sort By:
Pageof 28
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1995
Pharmacokinetics of chimeric L6 conjugated to indium-111- and yttrium-90-DOTA-peptide in tumor-bearing miceS J DeNardo, G R Zhong, Q Salako, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 7, 2007
Selecting an intervention time for intravascular enzymatic cleavage of peptide linkers to clear radioisotope from normal tissuesChristine L Hartmann Siantar, Gerald L DeNardo, Kit Lam, et al.
Nuclear Medicine and Biology|January 1, 1997
Reproducibility of operator processing for radiation dosimetryS Shen, G L DeNardo, S J DeNardo, et al.
Bioorganic & Medicinal Chemistry Letters|August 15, 2008
Development of TNKase-specific cleavable peptide-linked radioimmunoconjugates for radioimmunotherapyArutselvan Natarajan, Pappanaicken R Kumaresan, Sally J Denardo, et al.
Cancer|December 24, 1997
Impact of splenomegaly on therapeutic response and I-131-LYM-1 dosimetry in patients with B-lymphocytic malignanciesS Shen, G L DeNardo, R T O'Donnell, et al.
Chemical Communications (Cambridge, England)|March 30, 2007
Construction of di-scFv through a trivalent alkyne-azide 1,3-dipolar cycloadditionArutselvan Natarajan, Wenjun Du, Cheng-Yi Xiong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1990
Metabolism of indium chelates attached to monoclonal antibody: minimal transchelation of indium from benzyl-EDTA chelate in vivoS V Deshpande, R Subramanian, M J McCall, et al.
Nuclear Medicine and Biology|May 1, 1996
A radioimmunoimaging and MIRD dosimetry treatment planning program for radioimmunotherapyW D Erwin, M W Groch, D J Macey, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 21, 1998
A preliminary cell kinetics model of thrombocytopenia after radioimmunotherapyS Shen, G L DeNardo, T D Jones, et al.
European Journal of Nuclear Medicine|August 1, 1996
Application of the linear-quadratic model to myelotoxicity associated with radioimmunotherapyR B Wilder, G L DeNardo, S Sheri, et al.
Pageof 28